Financhill
Back

Citius Pharmaceuticals Vs. KBR Industry Stock Comparison

Sell
31

CTXR
Citius Pharmaceuticals

Last Price:
0.31
Seasonality Move:
21.66%
Sell
30

KBR
KBR

Last Price:
60.18
Seasonality Move:
0.56%
Sell
31
Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

  • The current Citius Pharmaceuticals [CTXR] share price is $0.33. The Score for CTXR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
KBR (KBR) is a Sell

Is KBR a Buy, Sell or Hold?

  • The current KBR [KBR] share price is $60.16. The Score for KBR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • KBR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

  • The Citius Pharmaceuticals share price today is $0.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.

KBR Stock Price Chart

What is KBR's stock price today?

  • The KBR share price today is $60.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBR is experiencing selling pressure, which indicates risk of future bearish movement.

CTXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 39.61 Sell
Chaikin Money Flow: 1360852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.35 - 0.41) Sell
Bollinger Bands (100): (0.39 - 0.77) Sell

KBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 28.75 Sell
Chaikin Money Flow: -6204215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.2 - 70.96) Sell
Bollinger Bands (100): (63.48 - 68.68) Sell

CTXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.39 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.44 Sell
200-day SMA: 0.65 Sell
8-day EMA: 0.39 Sell
20-day EMA: 0.39 Sell
50-day EMA: 0.45 Sell
200-day EMA: 0.63 Sell

KBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.26 Sell
20-day SMA: 68.58 Sell
50-day SMA: 66.43 Sell
200-day SMA: 64.08 Sell
8-day EMA: 68 Sell
20-day EMA: 68.27 Sell
50-day EMA: 67.34 Sell
200-day EMA: 64.19 Sell

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

KBR Earnings Growth & KBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.63 per share.

Citius Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

KBR Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):